Overview
Unichem Laboratories Limited is a pharmaceutical company that manufactures active pharmaceutical ingredients and operates through four divisions. It has five manufacturing facilities across India, enjoying numerous global certifications.
The company has a rich history of collaborations and initiatives, having set up various R&D centers and strategic plants since its inception in 1962, illustrating its commitment to growth and innovation.
Recent strategic moves include a significant acquisition by Ipca Laboratories Limited, which now holds majority control over Unichem, influencing its future trajectory and operational strategies.
Despite divesting some business components in the past, Unichem continues to expand its international presence, notably with a wholly owned subsidiary in China, reflecting its global ambitions.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
2,606 Cr
- Volatility
Moderate Risk
- P/E Ratio
8.3
- Industry P/E
32.3
- PEG Ratio
0.0
- P/B Ratio
1.1
- 52W High
668.00
- 52W Low
280.00
Financial Ratios
Sales CAGR
- 1Y
- 18.25%
- 3Y
- 22.56%
- 5Y
- 13.92%
- 10Y
- 3.84%
Profit CAGR
- 1Y
- 246.67%
- 3Y
- —
- 5Y
- —
- 10Y
- 5.52%
ROE
- TTM
- 5.98%
- 3Y
- -2.16%
- 5Y
- -0.73%
- 10Y
- 11.57%
ROCE
- TTM
- 6.30%
- 3Y
- -0.60%
- 5Y
- 0.30%
- 10Y
- -0.49%
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
